These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19913516)

  • 21. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
    Wang SZ; el-Fakahany EE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
    Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
    Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.
    Tränkle C; Weyand O; Schröter A; Mohr K
    Mol Pharmacol; 1999 Nov; 56(5):962-5. PubMed ID: 10531401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
    Eglen RM; Kenny BA; Michel AD; Whiting RL
    Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
    Redka DS; Pisterzi LF; Wells JW
    Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.
    May LT; Lin Y; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
    Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
    Hu JR; el-Fakahany EE
    Mol Pharmacol; 1990 Dec; 38(6):895-903. PubMed ID: 1701216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacology of McN-A-343.
    Mitchelson FJ
    Pharmacol Ther; 2012 Aug; 135(2):216-45. PubMed ID: 22643681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors.
    Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1997 Nov; 339(2-3):153-6. PubMed ID: 9473129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of an "Allosteric Site-Impaired" M
    Moo EV; Sexton PM; Christopoulos A; Valant C
    Mol Pharmacol; 2018 Nov; 94(5):1298-1309. PubMed ID: 30213802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
    Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
    Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
    Hu J; Wang SZ; el-Fakahany EE
    J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA; Miller RC; Eck M; Paquet JL
    Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transducer abstraction: a novel approach to the detection of partial agonist efficacy in radioligand binding studies.
    Christopoulos A; Grant MK; El-Fakahany EE
    J Pharmacol Toxicol Methods; 2000; 43(1):55-67. PubMed ID: 11091130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.
    Shivnaraine RV; Huang XP; Seidenberg M; Ellis J; Wells JW
    Biochemistry; 2012 Jun; 51(22):4518-40. PubMed ID: 22551249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors.
    Jakubík J; Randáková A; Zimčík P; El-Fakahany EE; Doležal V
    Sci Rep; 2017 Jan; 7():40381. PubMed ID: 28091608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
    Ehlert FJ; Oliff HS; Griffin MT
    J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A; Christopoulos A; Mitchelson F
    J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.